PMID: 9534829Apr 16, 1998Paper

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia

The British Journal of Psychiatry : the Journal of Mental Science
H M InskipB Barraclough

Abstract

The lifetime risks of suicide are generally quoted as 15% for affective disorder and alcoholism and 10% for schizophrenia, based on data from 1921-1975 and on calculations performed before computerised modelling techniques became available. This study recalculates the risk using contemporary data and modern techniques. Twenty-seven mortality studies provided data for affective disorder, 27 for alcohol dependence and 29 for schizophrenia. The proportion of the cohort who had died was plotted against the proportion of deaths from suicide. Modelling techniques fitted curves through the data points extrapolating them to cohort extinction, thus estimating the lifetime risk of suicide for each disorder. The lifetime risk was estimated at 6% for affective disorder. 7% for alcohol dependence and 4% for schizophrenia. The lifetime suicide risk figures often quoted in the literature appear to be too high.

References

Apr 1, 1977·The Journal of Nervous and Mental Disease·C P Miles
Oct 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·S B Guze, E Robins
Mar 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·E C Harris, B Barraclough

❮ Previous
Next ❯

Citations

Sep 15, 2000·Journal of Clinical Psychology·P M Kleespies, E L Dettmer
Sep 15, 2000·Journal of Clinical Psychology·G R Trezza, S M Popp
Feb 1, 2006·Irish Journal of Medical Science·H O'Connell, B A Lawlor
Dec 13, 2005·Social Psychiatry and Psychiatric Epidemiology·Fiona JuddAngela Komiti
Mar 2, 2006·Social Psychiatry and Psychiatric Epidemiology·Alexander GrinshpoonAlexander M Ponizovsky
Nov 19, 2004·European Archives of Psychiatry and Clinical Neuroscience·Barbara SchneiderTilman Wetterling
Aug 29, 2012·European Archives of Psychiatry and Clinical Neuroscience·Barbara Schneider
Jun 29, 2010·Comprehensive Psychiatry·Borut Skodlar, Josef Parnas
May 26, 2005·Journal of Affective Disorders·Julia M A SinclairElizabeth A King
Jun 9, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Florin A OrhaPierre Baumann
Jan 29, 2000·Biological Psychiatry·S E Hyman
May 30, 2002·Life Sciences·Martina C M Ryan, Jogin H Thakore
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Albert Hung Choy Wong, Hubert H M Van Tol
Jan 11, 2000·Journal of Affective Disorders·G W Blair-WestM L Eyeson-Annan
Sep 13, 2000·Clinical Psychology Review·J L Pearson, G K Brown
Mar 30, 2001·Schizophrenia Research·T TaiminenH Helenius
Dec 1, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·A P Boardman, D Healy
Dec 1, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·Z Rihmer
Dec 1, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·P Gorwood
Jul 26, 2012·Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees·Jacob M Appel
Aug 12, 1999·The Australian and New Zealand Journal of Psychiatry·P Boyce, F Judd
Jul 5, 2001·The Australian and New Zealand Journal of Psychiatry·G W Blair-West, G W Mellsop
May 7, 2002·The Australian and New Zealand Journal of Psychiatry·A KomitiA Street
Sep 22, 2009·Médecine sciences : M/S·Sarah DionIsabelle Dimier-Poisson
Jan 7, 2011·The New England Journal of Medicine·Mark A Frye
Dec 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kevin J BlackJoel S Perlmutter
Oct 7, 2010·Journal of Addictive Diseases·Giancarlo GiupponiMaurizio Pompili
May 4, 2012·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Erlend MorkFredrik A Walby
Jan 1, 2009·International Journal of Qualitative Studies on Health and Well-being·Marie RusnerMaria Nyström
Sep 8, 2009·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Sylwia FudalejFrederic C Blow
Jun 14, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Anna KlimkiewiczKirk J Brower
Mar 17, 2012·Social Cognitive and Affective Neuroscience·Zhenhao Shi, Shihui Han
Aug 11, 2007·International Clinical Psychopharmacology·A Carlo AltamuraHerbert Y Meltzer
Jun 23, 2001·BMJ : British Medical Journal·S DaviesA S Lee
Feb 16, 2005·Annual Review of Psychology·Thomas E JoinerLaRicka R Wingate
Mar 3, 2006·Health and Quality of Life Outcomes·Paul S F Yip, Yin Bun Cheung
Mar 21, 2007·Annals of General Psychiatry·Maurizio PompiliRoberto Tatarelli
Apr 24, 2007·Environmental Health Perspectives·Won Jin LeeDale P Sandler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
E C Harris, B Barraclough
Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism
S P PirkolaJ K Lönnqvist
© 2022 Meta ULC. All rights reserved